Y VECTORY THERAPEUTICS

Serial Number 79377825
Registration 7636697
700

Registration Progress

Application Filed
Jul 20, 2023
Under Examination
Approved for Publication
Nov 19, 2024
Published for Opposition
Nov 19, 2024
Registered
Jan 7, 2025

Trademark Image

Y VECTORY THERAPEUTICS

Basic Information

Serial Number
79377825
Registration Number
7636697
Filing Date
July 20, 2023
Registration Date
January 7, 2025
Published for Opposition
November 19, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2025
Registration
Registered
Classes
005 042 044

Rights Holder

VectorY B.V.

26
Address
Science Park 408
NL-1098 XH Amsterdam
NL

Ownership History

VectorY B.V.

Original Applicant
26
NL

VectorY B.V.

Owner at Publication
26
NL

VectorY B.V.

Original Registrant
26
NL

Legal Representation

Attorney
Douglas T. Johnson

USPTO Deadlines

Next Deadline
1988 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-07)
Due Date
January 07, 2031
Grace Period Ends
July 07, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Jul 26, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 5, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 5, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 7, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 15, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jan 27, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 26, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jan 7, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 7, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 19, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 19, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 7, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 27, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 27, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 27, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 24, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 29, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 28, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 10, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 9, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 6, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 7, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 31, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Viral systems, gene therapy systems, nucleic acid delivery systems, namely, viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neurodegenerative disease; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in gene therapy; pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in gene therapy
Class 042
Research, product development and consultancy in the field of biotechnology, biologics and medical science; research and product development in the field of pharmaceutics
Class 044
Gene and nucleic acid delivery by viral vectors, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics

Additional Information

Design Mark
The mark consists of the stacked wording "VECTORY THERAPEUTICS" in stylized dark blue lettering to the right of an incomplete circle comprised of green, light blue, and dark blue segments; inside this incomplete circle is a block letter "Y" comprised of green, light blue, and dark blue segments.
Color Claim
The colors blue and green are claimed as a feature of the mark.

Classification

International Classes
005 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"